X-154428787-T-TGGC
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_001183.6(ATP6AP1):c.114_116dup(p.Ala40dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,124,450 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00029 ( 0 hom., 5 hem., cov: 21)
Exomes 𝑓: 0.00012 ( 0 hom. 29 hem. )
Consequence
ATP6AP1
NM_001183.6 inframe_insertion
NM_001183.6 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.146
Genes affected
ATP6AP1 (HGNC:868): (ATPase H+ transporting accessory protein 1) This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-154428787-T-TGGC is Benign according to our data. Variant chrX-154428787-T-TGGC is described in ClinVar as [Likely_benign]. Clinvar id is 2058049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6AP1 | NM_001183.6 | c.114_116dup | p.Ala40dup | inframe_insertion | 1/10 | ENST00000369762.7 | NP_001174.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6AP1 | ENST00000369762.7 | c.114_116dup | p.Ala40dup | inframe_insertion | 1/10 | 1 | NM_001183.6 | ENSP00000358777 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000294 AC: 33AN: 112150Hom.: 0 Cov.: 21 AF XY: 0.000145 AC XY: 5AN XY: 34496
GnomAD3 genomes
AF:
AC:
33
AN:
112150
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
34496
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000129 AC: 7AN: 54469Hom.: 0 AF XY: 0.0000686 AC XY: 1AN XY: 14567
GnomAD3 exomes
AF:
AC:
7
AN:
54469
Hom.:
AF XY:
AC XY:
1
AN XY:
14567
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000124 AC: 126AN: 1012259Hom.: 0 Cov.: 31 AF XY: 0.0000890 AC XY: 29AN XY: 325761
GnomAD4 exome
AF:
AC:
126
AN:
1012259
Hom.:
Cov.:
31
AF XY:
AC XY:
29
AN XY:
325761
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000294 AC: 33AN: 112191Hom.: 0 Cov.: 21 AF XY: 0.000145 AC XY: 5AN XY: 34547
GnomAD4 genome
AF:
AC:
33
AN:
112191
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
34547
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at